For doctors who take a break from practice, coming back can be toughJune 16, 2015Business of Medicine
FDA panel backs evolocumab for lowering LDL in high-risk patientsJune 11, 2015Lipid DisordersCAD & AtherosclerosisBusiness of Medicine